REFERENCE
Vega-Ruiz A, O'Brien S, Cortes J, Kebriaei P, Thomas D, Kantarjian H, Ravandi F.Secondary myelodysplastic syndrome in a patient with Philadelphia-positive acute lymphoblastic leukemia after achieving a major molecular response with hyperCVAD plus imatinib mesylate. Leukemia Research 32: 1468-1471, No. 9, Sep 2008 - USA
Rights and permissions
About this article
Cite this article
Antineoplastics. React. Wkly. 1211, 7 (2008). https://doi.org/10.2165/00128415-200812110-00020
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-200812110-00020